Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Khadija, Hafidh"'
Autor:
Ghazal Talal Saeed, Montaser Nabeeh Al Smady, Gunjan Awatramani, Hessa Alqasimi, Mohammed Amaan Khokar, Mohamed Awad, Khadija Hafidh
Publikováno v:
European Journal of Case Reports in Internal Medicine (2024)
Introduction: This case report presents a rare instance of hypervirulent Klebsiella pneumoniae invasive syndrome (KPIS) without hepatic involvement. It highlights an atypical presentation as this syndrome is characterized by liver abscesses. Case Pre
Externí odkaz:
https://doaj.org/article/54cfd988986d466ebfa7183ed45f11d8
Autor:
Mohamed Hassanein, M Yakoob Ahmedani, Inass Shaltout, Majid Alabbood, Mehmet Akif Buyukbese, Khadija Hafidh, Shehla Shaikh, Lobna F. El Toony, Rakesh Kumar Sahay, Mohammed Ali Batais, Eman Alfadhli, Md Farid Uddin, Abdulaziz F Alfadhly, Mohan T Shenoy, Adibah Salleh, Naweed Alzaman, Eman Sheshah, Benabed Kebira, Reem Alamoudi, Zanariah Hussein
Publikováno v:
Diabetes Epidemiology and Management, Vol 16, Iss , Pp 100229- (2024)
Aims: The DAR 2020 survey summarised fasting practices and complications in people with type 2 diabetes (T2D) who fasted during Ramadan, and impact of pre-Ramadan diabetes education towards controlling the complications. Methods: Eight week post-Rama
Externí odkaz:
https://doaj.org/article/a58ef2241cc248749a0d10790d026b40
Autor:
Bachar Afandi, Khadija Hafidh, Rachid Malek, M Yakoob Ahmedani, Inass Shaltout, Reem Alamoudi, Zanariah Hussein, Mohamed Hassanein
Publikováno v:
Diabetes Epidemiology and Management, Vol 15, Iss , Pp 100217- (2024)
Introduction: The decision to fast or not is quite complex. Personal, medical and religious matters may influence it for individuals with diabetes. However, a diagnosis of diabetes does not constitute an automatic exemption from Ramadan fasting. We a
Externí odkaz:
https://doaj.org/article/72eb7968b3be467e8c9540390d29456d
Autor:
Mohamed Hassanein, Hani Sabbour, Fatheya Al Awadi, Salah Abusnana, Bachar Afandi, Juma Al Kaabi, Alaaeldin Bashier, Francesco Cosentino, Hassan El Tamimi, Mohammed Farghali, M. Hamed Farooqi, Khadija Hafidh, Hussein Heshmat, Rabih Hijazi, Abdul Jabbar, Sami Kenz, Seema Elkhider Nour, Abdullah Shehab, Jeff Shook, Mohamed Suliman, Hosam Zaky, Wael Almahmeed
Publikováno v:
Dubai Diabetes and Endocrinology Journal, Pp 1-22 (2023)
Background: Cardiovascular diseases (CVDs) are the major cause of mortality and disability in patients with type 2 diabetes mellitus (T2DM). The increased risk of major cardiovascular (CV) events in patients with T2DM causes an estimated 12-year redu
Externí odkaz:
https://doaj.org/article/d5c4827f3e394eedb38da4792e1979cf
Autor:
Bashair M. Mussa, Thenmozhi Venkatachalam, Ankita Srivastava, Abeer Al-Habshi, Elamin Abdelgadir, Alaaeldin Bashier, Fatheya Al Awadi, Khadija Hafidh, Rifat Hamoudi, Salah Abusnana
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Type 1 diabetes mellitus (T1DM) is a chronic metabolic disorder that mainly affects children and young adults. It is associated with debilitating and long-life complications. Therefore, understanding the factors that lead to the onset and de
Externí odkaz:
https://doaj.org/article/0515e1e0c60342d08afef77eae1740dd
Autor:
Khadija Hafidh, Nabila Ahmed Abdella
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Optimum glycemic control is necessary to reduce and even prevent the risk of micro- and macrovascular complications of type 1 diabetes mellitus (T1DM). The main aim of this study was to assess the prevalence of T1DM patients with
Externí odkaz:
https://doaj.org/article/5a0203193a22400396f899de87e11edc
Autor:
Ahmed Hassoun, Denish Kumar Dhanwal, Jalal Nafach, Yasmin Ajaz, Asif Majid Khan, Abdullah Ben Nakhi, Monira AlArouj, Khadija Hafidh, Majdi AlNajjar, Ahmed Reyas, Sana Qamar, Mohamed Alsayed, Ahmad Bdair
Publikováno v:
Dubai Diabetes and Endocrinology Journal, Pp 1-10 (2022)
Introduction: While ample evidence on improved glycemic control, weight reduction, and lowered blood pressure (BP) with sodium-glucose cotransporter type 2 inhibitors (SGLT2is) exists, real-world data on the potential benefit of SGLT2i on the diabeti
Externí odkaz:
https://doaj.org/article/059bfb4103f2495e97b4cf10defae7cc
Autor:
Khadija Hafidh, Rachid Malek, Khalid Al-Rubeaan, Adri Kok, Fahri Bayram, Akram Echtay, Viraj Rajadhyaksha, Ahmed Hadaoui
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
BackgroundWe evaluated the prevalence of vascular complications and associated risk factors in individuals with type 2 diabetes mellitus (T2DM) initiating second-line glucose-lowering therapy from the Middle East and Africa (MEA) cohort of the 3-year
Externí odkaz:
https://doaj.org/article/7cba735a76f7445abc964d9be0104d6f
Autor:
Elamin Abdelgadir, Maryam Alsaeed, Khadija Hafidh, Alaaeldin Bashier, Fauzia Rashid, Fawzi Altayb, Fatima Sayyah, Muhammad H. Farooqi, Fatheya Alawadi
Publikováno v:
Oman Medical Journal, Vol 34, Iss 4, Pp 290-296 (2019)
Objectives: A key aspect for the prevention of vascular complications in diabetes is control of hyperlipidemia, and that has always been a global challenge. The prevalence of diabetes mellitus in the UAE is estimated to be 18.98%. However, despite th
Externí odkaz:
https://doaj.org/article/8b33ab9091b74650b50846f224cf87c1
Autor:
Fatheya Alawadi, Elamin Abdelgadir, Alaaeldin Bashier, Mohamed Hassanein, Fauzia Rashid, Maryam Alsaeed, Khadija Hafidh, Mohamed Abdellatif Elsayed, Sona Abuelkheir, Muhammad H. Farooqi
Publikováno v:
Oman Medical Journal, Vol 34, Iss 1, Pp 20-25 (2019)
Objectives: In the UAE, the comparative prevalence of diabetes is reported as 18.98%, but there are very few studies evaluating glycemic control. Attaining the optimum glycemic control has been a global challenge over the years. However, there is a t
Externí odkaz:
https://doaj.org/article/a43b9ecaeda24cba959bfe9bc05adfb8